CBD oil: reported consumer uses and the legal framework

A CBD oil is a hemp extract diluted in a vegetable oil (MCT, hemp, olive). A distinction is made between full spectrum, which retains the minor cannabinoids and up to 0.30 % THC, broad spectrum, without THC but with the other compounds, and isolate, CBD purified to 99 %. Common concentrations range from 5 to 30 % CBD, or 500 to 3,000 mg per 10 ml bottle.

According to the IFOP 2022 survey commissioned by 60 millions de consommateurs, regular users cite managing stress and anxiety (≈ 43 %), sleep disturbance (≈ 39 %), chronic or occasional pain (≈ 26 %) and the search for relaxation (≈ 24 %). These figures are statements of use, not proof of efficacy: they authorise no brand to present these uses as validated benefits.

European regulation 1924/2006 governs health claims, and none is entered in the European register for CBD. Any assertion of the "reduces stress" or "improves sleep" type reclassifies the product as a medicine by presentation, within the meaning of article L.5111-1 of the French Public Health Code. MILDECA reminds us that no therapeutic benefit is demonstrated and that these claims remain prohibited.

A few clinical studies suggest an effect on social anxiety at doses of 300 to 600 mg in a single intake, far above the dosages usually found in shops. A 2019 observational study of 72 adults showed an improvement in the sleep score of some participants, without a placebo group. For pain, a few pieces of work suggest a signal in chronic patients, with no robust meta-analysis to date; the HAS has not included wellness CBD in its recommendations.

The finished product must contain at most 0.30 % THC, in accordance with the Conseil d'État decision of 29 December 2022. Synthetic cannabinoids (HHC, H4CBD, THCP) have been banned since June 2024. Since 15 May 2026, CBD food supplements without Novel Food authorisation have been withdrawn from the market, which includes sublingual oils sold as supplements. The EFSA provisionally safe daily intake, published on 9 February 2026, is 0.0275 mg/kg/day, or roughly 2 mg/day for 70 kg.

Check the concentration in mg/ml, the cannabinoid profile, the stated THC content and the origin of the hemp. Insist on a certificate of analysis from a third-party laboratory confirming the absence of pesticides, heavy metals and synthetic cannabinoids. A serious 10 ml oil at 10 % generally costs between €40 and €80; a very low price should raise a flag. Our CBD buying guide sets out these criteria in detail.

Use is not advised for pregnant and breastfeeding women, ANSES having proposed in 2025 that CBD be classified as presumed toxic for reproduction. It is likewise not advised for minors. A full-spectrum product may lead to a positive saliva test at the wheel. CBD inhibits CYP3A4 and CYP2C19: pharmaceutical advice is essential in the case of chronic treatment.

CBD is not a medicine. In case of stress or persistent difficulties, consult a healthcare professional.

How many drops to start with?

For a 10 % oil (about 5 mg per drop), 1 to 2 drops sublingually, once or twice a day, adjusting over 7 to 10 days.

Full spectrum or isolate?

Full spectrum offers a presumed entourage effect but leaves traces of THC detectable in saliva screening. Isolate is neutral on that point, without the claimed effect.

Is CBD oil reimbursed?

No. Only Epidyolex®, a purified CBD, is reimbursed for certain rare epilepsies on hospital prescription. That is not the same thing as a wellness oil sold freely.

Is CBD oil addictive?

The WHO considered in 2017 that pure CBD presents no potential for abuse or dependence, which does not remove the need for the usual precautions.